Skip to content


Anne Pariser

Vice President, Medical and Regulatory Affairs of Alltrna

Anne Pariser is the Vice President of Medical and Regulatory Affairs at Alltrna. Prior to joining Alltrna, Anne was the Director of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH). During her tenure at ORDR, she oversaw the Rare Diseases Clinical Research Network (RDCRN), a network of rare diseases research consortia focusing on research programs into more than 200 different rare diseases and other research programs. Additional research programs included the PaVe-GT gene therapy development program, which seeks to treat four ultra-rare diseases using a platform approach, grant programs to speed rare disease diagnoses and many-diseases-at-a-time strategies, and rare diseases informatics. Prior to ORDR, Anne worked at the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER), where she predominantly focused on rare diseases drug review and most notably founded the Rare Diseases Program, which focused on developing regulatory science, policy, and processes intended to facilitate rare disease drug development and review. Anne received her M.D. from Georgetown University School of Medicine and completed her Internal Medicine Internship and Residency at Georgetown University Medical Center. She is Board certified in Internal Medicine.